.jpg)
.png)
Telemedicine is Here to Stay
Article By:
Past President, Midwest Lipid Association
Founder, Mobile Health Team Lipids Clinic
Adjunct Assistant Professor of Pediatrics
University of Wisconsin School of Medicine and Public Health
Neenah and Wauwatosa, WI
Diplomate, American Board of Clinical Lipidology
Atherosclerosis occurs due to a complex interaction between dyslipidemia and proinflammatory molecules.(1) It is the key culprit for globally prevalent cardiovascular diseases (CVD).
Article By:
Preventive Cardiology Fellow In-Training
University of Chicago
Chicago, IL
President, Midwest Lipid Association
Scientist, Robarts Research Institute
Professor, Department of Physiology &
Pharmacology
Schulich School of Medicine & Dentistry
London, ON
Since its emergence, the highly virulent coronavirus disease 2019 (COVID-19) has infected over 50 million people worldwide, and its cardiovascular (CV) manifestations have become an important cause of morbidity and mortality.
Article By:
Department of Medicine
Rush University Medical Center
Chicago, IL
Lipid Clinic, Division of Cardiology
Rush University Medical Center
Chicago, IL
Director, Lipid Clinic
Director, Advanced Cardiac Imaging & Infiltrative Cardiac Disease Program
Division of Cardiology
Rush University Medical Center
Chicago, IL
Diplomate, American Board of Clinical Lipidology
Atherosclerosis is the leading cause of death and disability globally, with the highest burden continuing to have dominant impact in the developing world.(1) Lipids play a major role in the development of atherosclerosis, but contemporary models demonstrate they are not the sole determinant of disease.
Article By:
Cardiovascular Fellow In-Training
University of Chicago, NorthShore
Evanston, IL
Preventive Cardiology Fellow In-Training
University of Chicago
Chicago, IL
Director, Preventive Cardiology
NorthShore University HealthSystem
Evanston, IL
Diplomate, American Board of Clinical Lipidology
“Every day you may make progress. Every step may be fruitful. Yet there will stretch out before you an ever-lengthening, everascending, ever-improving path. You know you will never get to the end of the journey. But this, so far from discouraging, only adds to the joy and glory of the climb.” – Winston Churchill
Article By:
Editor, LipidSpin
Medical Director, Lipid Clinic and Physician Advisor
Ascension Wisconsin All Saints
Racine, WI
Diplomate, American Board of Clinical Lipidology
“In the middle of every difficulty lies opportunity.” – Albert Einstein
Article By:
President, Midwest Lipid Association
Scientist, Robarts Research Institute
Professor, Department of Physiology & Pharmacology
Schulich School of Medicine & Dentistry
London, ON
It was about this time last year that our corner of the world was beginning to grasp the stark reality of a novel virus which had made its way around the world with devastating results. In some ways, it barely feels like a moment has passed since then – in many others, the personal and professional spaces in which we exist have been altered forever.
Article By:
President, Pacific Lipid Association
Director, Clinical Associate Professor
Wellness Center
Idaho State University
Kasiska Division of Health Sciences
Pocatello, ID
To my fellow National Lipid Association members, I am happy to welcome you to the first LipidSpin edition of 2021. Management of Residual Risk remains a pertinent topic in the field of Clinical Lipidology, and I feel our colleagues within the Pacific and Midwest chapters have done and excellent job handling the topic within these pages.
Article By:
President, National Lipid Association
Professor and Vice Chair, Department of Clinical Pharmacy
Professor, Department of Family Medicine
University of Colorado Anschutz Medical Campus
Aurora, CO
JACKSONVILLE, Fla. and ORANGEBURG, N.Y., March 02, 2021 -- The National Lipid Association (NLA), the preeminent global authority on lipid disorders, and Paradigm Medical Communications, LLC (Paradigm), a multiple award-winning medical education company, are proud to announce their collaborative partnership to design and implement How Low Do You Go? Novel Strategies to Address LDL-C Limbo, an 18-month blended learning, certified continuing education curriculum for clinicians, comprising live and online activities, to launch in May 2021.
Be sure to make plans to join us in June (VIRTUALLY) and September (IN-PERSON) for our premier educational events in 2021:
Summer of Lipids: A Virtual Education Experience with the NLA · June 4-6, 2021